Uses and potential for cardiac magnetic resonance imaging in patients with cardiac resynchronisation pacemakers

References

• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the sp ecial contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Swoboda PP, Plein S. Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure. Expert Rev Cardiovasc Ther. 2014;12(1):45–55.
   PubMedGoogle Scholar
• Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143(3):398–405.
   PubMed Web of Science ®Google Scholar
• Sundell J, Engblom E, Koistinen J, et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol. 2004;43(6):1027–1033.
   PubMed Web of Science ®Google Scholar
• Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol. 1998;32(7):1825–1831.
   PubMed Web of Science ®Google Scholar
• Inage T, Yoshida T, Hiraki T, et al. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Europace. 2008;10(3):379–383.
   PubMed Web of Science ®Google Scholar
• Morani G, Gasparini M, Zanon F, et al. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the contak Italian registry. Europace. 2013;15(9):1273–1279.
   PubMed Web of Science ®Google Scholar
• Erlebacher JA, Cahill PT, Pannizzo F, et al. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol. 1986;57(6):437–440.
   PubMed Web of Science ®Google Scholar
• Langman DA, Goldberg IB, Finn JP, et al. Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging. 2011;33(2):426–431.
   PubMed Web of Science ®Google Scholar
• Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace. 2008;10(3):336–346.
   PubMed Web of Science ®Google Scholar
• Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med. 2017;376(8):755–764.
   PubMed Web of Science ®Google Scholar
• Strom JB, Whelan JB, Shen C, et al. Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices. Heart Rhythm. 2017;14(8):1138–1144.
   PubMed Web of Science ®Google Scholar
• Bertelsen L, Petersen HH, Philbert BT, et al. Safety of magnetic resonance scanning without monitoring of patients with pacemakers. Europace. European pacing, arrhythmias, and cardiac electrophysiology : Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(5):818–823.
   PubMed Web of Science ®Google Scholar
• Bertini M, Mele D, Malagu M, et al. Cardiac resynchronization therapy guided by multimodality cardiac imaging. Eur J Heart Fail. 2016;18(11):1375–1382.
   PubMed Web of Science ®Google Scholar
• Behar JM, Claridge S, Jackson T, et al. The role of multi modality imaging in selecting patients and guiding lead placement for the delivery of cardiac resynchronization therapy. Expert Rev Cardiovasc Ther. 2017;15(2):93–107.
   PubMed Web of Science ®Google Scholar
• Indik JH, Gimbel JR, Abe H, et al. HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153.
   PubMed Web of Science ®Google Scholar
• Oshinski JN, Delfino JG, Sharma P, et al. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson. 2010;12:55.
   PubMed Web of Science ®Google Scholar
• Westbrook C, Roth C, Talbot J. MRI in practice. 4th ed. New Jersey, USA: Wiley-Blackwell; 2011.
   Google Scholar
• Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002.
   PubMed Web of Science ®Google Scholar
• Leyva F, Foley PW, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:29.
   PubMed Web of Science ®Google Scholar
• Zhou W, Hou X, Piccinelli M, et al. 3D fusion of LV venous anatomy on fluoroscopy venograms with epicardial surface on SPECT myocardial perfusion images for guiding CRT LV lead placement. JACC Cardiovasc Imaging. 2014;7(12):1239–1248.
   PubMed Web of Science ®Google Scholar
• Friehling M, Chen J, Saba S, et al. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol. Circ Cardiovasc Imaging. 2011;4(5):532–539.
   PubMed Web of Science ®Google Scholar
• Chitiboi T, Axel L. Magnetic resonance imaging of myocardial strain: A review of current approaches. J Magn Reson Imaging. 2017;46(5):1263–1280.
   PubMed Web of Science ®Google Scholar
• Hartlage GR, Suever JD, Clement-Guinaudeau S, et al. Prediction of response to cardiac resynchronization therapy using left ventricular pacing lead position and cardiovascular magnetic resonance derived wall motion patterns: a prospective cohort study. J Cardiovasc Magn Reson. 2015;17:57.
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Traber F, Schild HH. Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part I. Technical considerations and clinical applications. Radiology. 2008;246(3):675–696.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy R, Pednekar A, Atweh LA. et al. Clinical validation of free breathing respiratory triggered retrospectively cardiac gated cine balanced steady-state free precession cardiovascular magnetic resonance in sedated children. J Cardiovasc Magn Reson. 2015;17(1):1.
   PubMedGoogle Scholar
• Sommer T, Bauer W, Fischbach K, et al. MR imaging in patients with cardiac pacemakers and implantable cardioverter defibrillators. RoFo: Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin. 2017;189(3):204–217.
   PubMedGoogle Scholar
• Alfudhili K, Masci PG, Delacoste J, et al. Current artefacts in cardiac and chest magnetic resonance imaging: tips and tricks. Br J Radiol. 2016;89(1062):20150987.
   PubMed Web of Science ®Google Scholar
• Hilbert S, Jahnke C, Loebe S. et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality. Eur Heart J Cardiovasc Imaging. 2018;19(9):1051–1061.
   PubMed Web of Science ®Google Scholar
• Schwitter J, Gold MR, Al Fagih A, et al. Image quality of cardiac magnetic resonance imaging in patients with an implantable cardioverter defibrillator system designed for the magnetic resonance imaging environment. Circ Cardiovasc Imaging. 2016;9:5.
   Web of Science ®Google Scholar
• Chimura M, Onishi T, Tsukishiro Y, et al. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy. Heart. 2017;103(9):679–686.
   PubMed Web of Science ®Google Scholar
• Sabzevari K, Oldman J, Herrey AS, et al. Provision of magnetic resonance imaging for patients with ‘MR-conditional’ cardiac implantable electronic devices: an unmet clinical need. Europace. European pacing, arrhythmias, and cardiac electrophysiology : Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(3):425–431.
   PubMed Web of Science ®Google Scholar
• Mason S, Osborn JS, Dhar R, et al. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after magnasafe. J Cardiovasc Electrophysiol. 2017;28(12):1468–1474.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the replace registry. Circulation. 2010;122(16):1553–1561.
   PubMed Web of Science ®Google Scholar
• Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med. 2017;377(26):2555–2564.
   PubMed Web of Science ®Google Scholar
• Bastian D, Ebrahim IO, Chen JY, et al. Real-world geographic variations in the use of cardiac implantable electronic devices-The PANORAMA 2 observational cohort study. PACE. 2018, pages 978-989.
   Google Scholar
• Khidir MJ, Delgado V, Ajmone Marsan N, et al. Mechanical dyssynchrony in patients with heart failure and reduced ejection fraction: how to measure? Curr Opin Cardiol. 2016;31(5):523–530.
   PubMed Web of Science ®Google Scholar
• Jenkins C, Moir S, Chan J, et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J. 2009;30(1):98–106.
   PubMed Web of Science ®Google Scholar
• Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34.
   PubMed Web of Science ®Google Scholar
• de Haan S, de Boer K, Commandeur J, et al. Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: discrepancy between cardiac magnetic resonance imaging and 2D echocardiography. Neth Heart J. 2014;22(10):449–455.
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Elsik M, Broughton A, et al. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace. 2010;12(5):708–713.
   PubMed Web of Science ®Google Scholar
• Sohal M, Duckett SG, Zhuang X. et al. A prospective evaluation of cardiovascular magnetic resonance measures of dyssynchrony in the prediction of response to cardiac resynchronization therapy. J Cardiovasc Magn Reson. 2014;16(1):58.
   PubMedGoogle Scholar
• Taylor RJ, Umar F, Panting JR, et al. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: A feature-tracking and contrast-enhanced cardiovascular magnetic resonance study. Heart Rhythm. 2016;13(2):481–489.
   PubMed Web of Science ®Google Scholar
• Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Fail Rev. 2017;22(4):465–476.
   PubMed Web of Science ®Google Scholar
• Knebel F, Schattke S, Bondke H, et al. Circumferential 2D-strain imaging for the prediction of long term response to cardiac resynchronization therapy. Cardiovasc Ultrasound. 2008;6(1):28.
   PubMedGoogle Scholar
• Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e578–e622.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guallar E, Weiss RG, et al. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients. Heart Rhythm. 2016;13(8):1661–1666.
   PubMed Web of Science ®Google Scholar